BioLife Solutions Inc (BLFS)

Currency in USD
33.91
+0.11(+0.33%)
Real-time Data·
Advertisement
Earnings results expected today
Trading near 52-week High
BLFS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
33.6034.32
52 wk Range
17.8634.32
Key Statistics
Prev. Close
33.8
Open
33.61
Day's Range
33.6-34.32
52 wk Range
17.86-34.32
Volume
167.39K
Average Volume (3m)
1.11M
1-Year Change
60.7871%
Book Value / Share
7.71
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BLFS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
31.13
Downside
-8.21%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

BioLife Solutions Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

2 Buy
7 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 31.13
(-8.21% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Stephens
Hold---Downgrade27/07/2026
Jefferies
Hold31.00-8.58%30.00Downgrade23/07/2026
H.C. Wainwright
Hold31.00-8.58%32.00Downgrade23/07/2026
TD Cowen
Hold31.00-8.58%33.00Downgrade23/07/2026
Craig-Hallum
Hold31.00-8.58%-Downgrade22/07/2026

BioLife Solutions Inc Earnings Call Summary for Q1/2026

  • Q1 2026 revenue hit $27.5M, up 25% YoY and beating forecasts by 7.09%; EPS of $0.02 met expectations with GAAP net income of $1.2M.
  • Biopreservation Media franchise drove growth, accounting for 85%+ of revenue; stock surged 6.39% aftermarket to $22.20.
  • Gross margin declined to 64% from 67% due to temporary manufacturing yield issues; management expects resolution and margin expansion ahead.
  • Company maintains full-year revenue growth guidance of 17-20%; quarterly EPS projected to rise from $0.03 in Q2 to $0.06 in Q4 2026.
  • Analysts maintain strong buy consensus with $30-34 price targets; company expects profitability despite elevated R&D and operational expenses.
Last Updated: 08/05/2026, 01:40
Read Full Transcript

Earnings

Latest Release
07/05/2026
EPS / Forecast
0.02 / 0.02
Revenue / Forecast
27.5M / 25.68M
EPS Revisions
Last 90 days

Compare BLFS to Peers and Sector

Metrics to compare
BLFS
Peers
Sector
Relationship
P/E Ratio
−148.0x−11.9x−0.4x
PEG Ratio
−2.150.000.00
Price/Book
4.5x1.7x2.6x
Price / LTM Sales
16.3x2.7x3.0x
Upside (Analyst Target)
−8.3%10.7%51.8%
Fair Value Upside
Unlock3.3%7.2%Unlock

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
25.10M51.37%848.23M
Other Institutional Investors
29.25M48.63%988.79M
Public Companies & Retail Investors
0.000.00%0.00
Total
54.35M100.00%1.84B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
T. Rowe Price Group, Inc.13.40%6,546,641221,276
BlackRock, Inc.12.49%6,101,765206,240

People Also Watch

41.570
COGT
-1.66%
19.49
SNDX
-2.16%
11.03
RGNX
+5.05%
194.87
MOD
+0.13%
19.29
LEGN
+1.23%

FAQ

What Is the BioLife Solutions (NASDAQ: BLFS) Share Price Today?

The BioLife Solutions stock price today is 33.91 USD.

What Stock Exchange Does BioLife Solutions (BLFS) Trade On?

BioLife Solutions is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for BioLife Solutions?

The stock symbol (also called a 'ticker') for BioLife Solutions is "BLFS."

What Is the Current BioLife Solutions Market Capitalisation?

As of today, BioLife Solutions (NASDAQ: BLFS) market cap is 1.66B USD.

What Is BioLife Solutions's (BLFS) Earnings Per Share (TTM)?

The BioLife Solutions EPS is currently -0.24 (Trailing Twelve Months).

When Is the Next BioLife Solutions Earnings Date?

BioLife Solutions's next earnings report will be released on 06/08/2026.

Is BLFS a Buy or Sell From a Technical Analyst Perspective?

Based on today's BioLife Solutions moving averages and other technical indicators, the daily buy/sell signal for BLFS stock is Strong Buy.

How Many Times Has BioLife Solutions Stock Split?

BioLife Solutions has split 2 times. (See the BLFS stock split history page for full effective split date and price information.)

How Many Employees Does BioLife Solutions Have?

BioLife Solutions has 155 employees, based on their latest Companies House report.

What is the current trading status of BioLife Solutions (NASDAQ: BLFS)?

As of 06/08/2026, BioLife Solutions (BLFS) is trading at a share price of 33.91 USD, with a previous close of 33.80 USD. The stock has fluctuated within a day range of 33.60 USD to 34.32 USD, while its 52-week range spans from 17.86 USD to 34.32 USD.

What Is BioLife Solutions (BLFS) Price Target According to Analysts?

The average 12-month price target for BioLife Solutions is 31.13 USD, with a high estimate of 33 USD and a low estimate of 30 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an -8.21% Downside potential.

What Is the BLFS Premarket Price?

BLFS's last pre-market stock price is 33.17 USD. The pre-market share volume is 2,160.00, and the stock has decreased by -0.63, or -1.86%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.